Skip to content
10-Q

Quarterly Report

Caribou Biosciences, Inc. CRBU

0001619856-25-000043

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 93M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $28.49M
Current Liabilities Q1 2025 · Dec 31, 2024 $30.65M
Total Liabilities Q1 2025 · Mar 31, 2025 $56.43M
Total Liabilities Q1 2025 · Dec 31, 2024 $60.36M
Current Assets Q1 2025 · Mar 31, 2025 $217.32M
Current Assets Q1 2025 · Dec 31, 2024 $219.38M
Total Assets Q1 2025 · Mar 31, 2025 $273.66M
Total Assets Q1 2025 · Dec 31, 2024 $313.31M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $16.29M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $49.4M
Shares Diluted Q1 2025 · Mar 31, 2024 89.3M sh
Capex Q1 2025 · Mar 31, 2024 $1.45M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$37.2M
Stockholders Equity Q1 2025 · Mar 31, 2024 $343.29M
Stockholders Equity Q1 2025 · Dec 31, 2023 $368.4M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.46
Eps Basic Q1 2025 · Mar 31, 2024 −$0.46
Sga Expense Q1 2025 · Mar 31, 2024 $14.64M
Rd Expense Q1 2025 · Mar 31, 2024 $33.79M
Net Income Q1 2025 · Mar 31, 2024 −$41.23M
Operating Income Q1 2025 · Mar 31, 2024 −$46M
Revenue Q1 2025 · Mar 31, 2024 $2.43M